Welcome to LookChem.com Sign In|Join Free
  • or
GRAMICIDIN C is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

113-73-5

Post Buying Request

113-73-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

113-73-5 Usage

Originator

Gramoderm,Schering,US,1949

Definition

A cyclic peptide that acts on gram-positive bacteria.

Manufacturing Process

5 lb of acid precipitated solid (Hotchkiss, Advances in Enzymology, pages 157- 158) from 30 gal of tyrothricin fermentation liquor containing about 40 g (2%)of tyrothricin were extracted with 12 liters of absolute ethyl alcohol and filtered. The filtrate was evaporated in vacuo to 1 liter, and the concentrate extracted twice with 1 liter of pentane. The pentane layers were discarded.40 g of decolorizing charcoal were added to the pentane-extracted filtrate and filtered off. To 500 ml of the charcoal-treated filtrate were added 200 ml benzene and 300 ml water, the whole shaken thoroughly, centrifuged, and the benzene layer separated. This treatment of the charcoal-treated filtrate was repeated twice, all benzene fractions were combined and evaporated in vacuo. 200 ml of absolute acetone were added to the residue and concentrated by boiling to 150 ml. The concentrate was refrigerated overnight. The crystals which had formed in the concentrate were filtered off, and the mother liquor concentrated first to 50 ml and then to 25 ml, the two concentrates refrigerated overnight, and the formed crystals filtered off. Total yield of crystalline gramicidin was 3.85 g = 19.2% of estimated tyrothricin in the initial material. The combined crystal crops were redissolved in 50 ml absolute acetone, and the solution refrigerated overnight. After filtering, the formed crystals were dried in vacuo. The total yield of crystalline gramicidin thus obtained was 2.5 g.

Therapeutic Function

Antibacterial

Purification Methods

Gramicidin S crystallises from EtOH. The di-HCl crystallises from EtOH (+ few drops of HCl) with m 277-278o (see below). [NMR: Gibbons et al. Nature 227 840 1970, Beilstein 26 III/IV 4273.]

Check Digit Verification of cas no

The CAS Registry Mumber 113-73-5 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 1,1 and 3 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 113-73:
(5*1)+(4*1)+(3*3)+(2*7)+(1*3)=35
35 % 10 = 5
So 113-73-5 is a valid CAS Registry Number.
InChI:InChI=1/C60H92N12O10/c1-35(2)31-43-53(75)67-45(33-39-19-11-9-12-20-39)59(81)71-29-17-25-47(71)55(77)70-50(38(7)8)58(80)64-42(24-16-28-62)52(74)66-44(32-36(3)4)54(76)68-46(34-40-21-13-10-14-22-40)60(82)72-30-18-26-48(72)56(78)69-49(37(5)6)57(79)63-41(23-15-27-61)51(73)65-43/h9-14,19-22,35-38,41-50H,15-18,23-34,61-62H2,1-8H3,(H,63,79)(H,64,80)(H,65,73)(H,66,74)(H,67,75)(H,68,76)(H,69,78)(H,70,77)/t41-,42-,43-,44-,45+,46+,47-,48-,49-,50-/m0/s1

113-73-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name gramicidin S

1.2 Other means of identification

Product number -
Other names Gramicin S-A

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:113-73-5 SDS

113-73-5Synthetic route

Cyclo[(Val-Orn-(Cbz)-Leu-DPhe-Pro)2]
15207-29-1

Cyclo[(Val-Orn-(Cbz)-Leu-DPhe-Pro)2]

Gramicidin S
113-73-5

Gramicidin S

Conditions
ConditionsYield
With hydrogen; palladium In acetic acid for 4h;90%
With hydrogen; palladium on activated charcoal Hydrogenolysis;
With hydrogen
D-Phe-Pro-Val-Orn-Leu-D-Phe-Pro-Val-Orn-Leu
83830-88-0

D-Phe-Pro-Val-Orn-Leu-D-Phe-Pro-Val-Orn-Leu

Gramicidin S
113-73-5

Gramicidin S

Conditions
ConditionsYield
at 150℃; for 4h; Inert atmosphere; Neat (no solvent);87%
[Orn(Boc)2,2']gramicidin
41839-95-6

[Orn(Boc)2,2']gramicidin

Gramicidin S
113-73-5

Gramicidin S

Conditions
ConditionsYield
With trifluoroacetic acid In dichloromethane for 0.5h;78%
With trifluoroacetic acid In dichloromethane for 1h;
With chlorotriisopropylsilane; trifluoroacetic acid In water for 1.5h;
With trifluoroacetic acid In water at 20℃; for 1h;57 mg
H-(D-Phe-Pro-Val-Orn-Leu)2-ONSu

H-(D-Phe-Pro-Val-Orn-Leu)2-ONSu

Gramicidin S
113-73-5

Gramicidin S

Conditions
ConditionsYield
With pyridine In N,N-dimethyl-formamide at 25℃; for 24h;65%
C70H110N12O15

C70H110N12O15

Gramicidin S
113-73-5

Gramicidin S

Conditions
ConditionsYield
Stage #1: C70H110N12O15 With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide
Stage #2: With trifluoroacetic acid
53%
(S)-2-[(S)-5-tert-Butoxycarbonylamino-2-((S)-2-{[(S)-1-((R)-2-tert-butoxycarbonylamino-3-phenyl-propionyl)-pyrrolidine-2-carbonyl]-amino}-3-methyl-butyrylamino)-pentanoylamino]-4-methyl-pentanoic acid 2,5-dioxo-pyrrolidin-1-yl ester

(S)-2-[(S)-5-tert-Butoxycarbonylamino-2-((S)-2-{[(S)-1-((R)-2-tert-butoxycarbonylamino-3-phenyl-propionyl)-pyrrolidine-2-carbonyl]-amino}-3-methyl-butyrylamino)-pentanoylamino]-4-methyl-pentanoic acid 2,5-dioxo-pyrrolidin-1-yl ester

A

Gramicidin S
113-73-5

Gramicidin S

B

cyclo(D-Phe-Pro-Val-Orn-Leu)

cyclo(D-Phe-Pro-Val-Orn-Leu)

Conditions
ConditionsYield
Stage #1: (S)-2-[(S)-5-tert-Butoxycarbonylamino-2-((S)-2-{[(S)-1-((R)-2-tert-butoxycarbonylamino-3-phenyl-propionyl)-pyrrolidine-2-carbonyl]-amino}-3-methyl-butyrylamino)-pentanoylamino]-4-methyl-pentanoic acid 2,5-dioxo-pyrrolidin-1-yl ester With trifluoroacetic acid dealkoxycarbonylation;
Stage #2: With pyridine In N,N-dimethyl-formamide at 25℃; for 24h; Dimerization; cyclization;
A 38%
B 15%
Boc-D-Phe-Pro-Val-Orn(Boc)-OH
917501-50-9

Boc-D-Phe-Pro-Val-Orn(Boc)-OH

H-Leu-oxime resin

H-Leu-oxime resin

A

Gramicidin S
113-73-5

Gramicidin S

B

cyclo(D-Phe-Pro-Val-Orn-Leu)

cyclo(D-Phe-Pro-Val-Orn-Leu)

Conditions
ConditionsYield
Stage #1: Boc-D-Phe-Pro-Val-Orn(Boc)-OH; H-Leu-oxime resin With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; benzotriazol-1-ol
Stage #2: With trifluoroacetic acid In dichloromethane for 0.5h;
Stage #3: With acetic acid; N-ethyl-N,N-diisopropylamine In 1,4-dioxane at 25℃; for 24h;
A 35%
B n/a
H-D-Phe-Pro-Val-Orn-Leu-ONSu*TFA

H-D-Phe-Pro-Val-Orn-Leu-ONSu*TFA

A

Gramicidin S
113-73-5

Gramicidin S

B

cyclo(D-Phe-Pro-Val-Orn-Leu)

cyclo(D-Phe-Pro-Val-Orn-Leu)

Conditions
ConditionsYield
With pyridine In N,N-dimethyl-formamide at 25℃; for 24h; Yield given. Yields of byproduct given;
D-Phe-L-Pro
51926-52-4

D-Phe-L-Pro

Fmoc-protected immobolized peptide

Fmoc-protected immobolized peptide

Gramicidin S
113-73-5

Gramicidin S

Conditions
ConditionsYield
Yield given. Multistep reaction;
TentaGel-PEG-CONH-CH2CH2S-Leu-Orn-Val-Pro-D-Phe-Leu-Orn-Val-Pro-D-Phe-NH2

TentaGel-PEG-CONH-CH2CH2S-Leu-Orn-Val-Pro-D-Phe-Leu-Orn-Val-Pro-D-Phe-NH2

Gramicidin S
113-73-5

Gramicidin S

Conditions
ConditionsYield
Stage #1: TentaGel-PEG-CONH-CH2CH2S-Leu-Orn-Val-Pro-D-Phe-Leu-Orn-Val-Pro-D-Phe-NH2 With 3-(N-morpholino)propanesulfonate buffer; GrsB TE at 37℃; for 3h; pH=7.0; Enzymatic reaction;
Stage #2: With trifluoroacetic acid In water
(S)-2-[(S)-5-Amino-2-((S)-2-{[(S)-1-((R)-2-amino-3-phenyl-propionyl)-pyrrolidine-2-carbonyl]-amino}-3-methyl-butyrylamino)-pentanoylamino]-4-methyl-pentanoic acid 2,5-dioxo-pyrrolidin-1-yl ester
151812-96-3

(S)-2-[(S)-5-Amino-2-((S)-2-{[(S)-1-((R)-2-amino-3-phenyl-propionyl)-pyrrolidine-2-carbonyl]-amino}-3-methyl-butyrylamino)-pentanoylamino]-4-methyl-pentanoic acid 2,5-dioxo-pyrrolidin-1-yl ester

Gramicidin S
113-73-5

Gramicidin S

Conditions
ConditionsYield
With pyridine In N,N-dimethyl-formamide at 25℃; for 24h;
Fmoc-Val-OH
68858-20-8

Fmoc-Val-OH

Boc-D-Phe-OH
18942-49-9

Boc-D-Phe-OH

Fmoc-Pro-OH
71989-31-6

Fmoc-Pro-OH

Fmoc-Orn(Boc)-OH
109425-55-0

Fmoc-Orn(Boc)-OH

Fmoc-Leu-D-Phe-Pro-Val-Orn(Boc)-Leu-(4-sulfamylbutyryl AM resin)

Fmoc-Leu-D-Phe-Pro-Val-Orn(Boc)-Leu-(4-sulfamylbutyryl AM resin)

Gramicidin S
113-73-5

Gramicidin S

Conditions
ConditionsYield
Multistep reaction;
Boc-D-Phe-Pro-Val-Orn(Boc)-Leu-D-Phe-Pro-Val-Orn(Boc)-OH

Boc-D-Phe-Pro-Val-Orn(Boc)-Leu-D-Phe-Pro-Val-Orn(Boc)-OH

H-Leu-oxime resin

H-Leu-oxime resin

A

Gramicidin S
113-73-5

Gramicidin S

B

C60H92N12O10

C60H92N12O10

Conditions
ConditionsYield
Stage #1: Boc-D-Phe-Pro-Val-Orn(Boc)-Leu-D-Phe-Pro-Val-Orn(Boc)-OH; H-Leu-oxime resin With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; benzotriazol-1-ol
Stage #2: With trifluoroacetic acid In dichloromethane for 0.5h;
Stage #3: With acetic acid; N-ethyl-N,N-diisopropylamine In 1,4-dioxane at 25℃; for 24h;
A 56 % Chromat.
B 15 % Chromat.
H-Val-Orn(Z)-OBzl

H-Val-Orn(Z)-OBzl

Gramicidin S
113-73-5

Gramicidin S

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: HOBt; EDCI / CH2Cl2 / 3 h / 0 - 20 °C
2.1: HCl / dioxane / 0.5 h / 20 °C
3.1: 3.21 g / HOBt; EDCI / CH2Cl2 / 3 h / 0 - 20 °C
4.1: hydrogen / Pd/C / methanol / 15 h
5.1: 1.90 g / NaOH / methanol; dioxane; H2O / 15 h / 20 °C
6.1: BOP; HOBt
6.2: trifluoroacetic acid / CH2Cl2 / 0.5 h
6.3: 35 percent / iPr2NEt; acetic acid / dioxane / 24 h / 25 °C
View Scheme
Boc-Val-Orn(Z)-OBzl

Boc-Val-Orn(Z)-OBzl

Gramicidin S
113-73-5

Gramicidin S

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1.1: HCl / dioxane / 0.5 h / 20 °C
2.1: HOBt; EDCI / CH2Cl2 / 3 h / 0 - 20 °C
3.1: HCl / dioxane / 0.5 h / 20 °C
4.1: 3.21 g / HOBt; EDCI / CH2Cl2 / 3 h / 0 - 20 °C
5.1: hydrogen / Pd/C / methanol / 15 h
6.1: 1.90 g / NaOH / methanol; dioxane; H2O / 15 h / 20 °C
7.1: BOP; HOBt
7.2: trifluoroacetic acid / CH2Cl2 / 0.5 h
7.3: 35 percent / iPr2NEt; acetic acid / dioxane / 24 h / 25 °C
View Scheme
H-Pro-Val-Orn(Z)-OBzl

H-Pro-Val-Orn(Z)-OBzl

Gramicidin S
113-73-5

Gramicidin S

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: 3.21 g / HOBt; EDCI / CH2Cl2 / 3 h / 0 - 20 °C
2.1: hydrogen / Pd/C / methanol / 15 h
3.1: 1.90 g / NaOH / methanol; dioxane; H2O / 15 h / 20 °C
4.1: BOP; HOBt
4.2: trifluoroacetic acid / CH2Cl2 / 0.5 h
4.3: 35 percent / iPr2NEt; acetic acid / dioxane / 24 h / 25 °C
View Scheme
Boc-D-Phe-Pro-Val-Orn-OH

Boc-D-Phe-Pro-Val-Orn-OH

Gramicidin S
113-73-5

Gramicidin S

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: 1.90 g / NaOH / methanol; dioxane; H2O / 15 h / 20 °C
2.1: BOP; HOBt
2.2: trifluoroacetic acid / CH2Cl2 / 0.5 h
2.3: 35 percent / iPr2NEt; acetic acid / dioxane / 24 h / 25 °C
View Scheme
Boc-Pro-Val-Orn(Z)-OBzl

Boc-Pro-Val-Orn(Z)-OBzl

Gramicidin S
113-73-5

Gramicidin S

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: HCl / dioxane / 0.5 h / 20 °C
2.1: 3.21 g / HOBt; EDCI / CH2Cl2 / 3 h / 0 - 20 °C
3.1: hydrogen / Pd/C / methanol / 15 h
4.1: 1.90 g / NaOH / methanol; dioxane; H2O / 15 h / 20 °C
5.1: BOP; HOBt
5.2: trifluoroacetic acid / CH2Cl2 / 0.5 h
5.3: 35 percent / iPr2NEt; acetic acid / dioxane / 24 h / 25 °C
View Scheme
Boc-D-Phe-Pro-Val-Orn(Z)-OBzl
917501-48-5

Boc-D-Phe-Pro-Val-Orn(Z)-OBzl

Gramicidin S
113-73-5

Gramicidin S

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: hydrogen / Pd/C / methanol / 15 h
2.1: 1.90 g / NaOH / methanol; dioxane; H2O / 15 h / 20 °C
3.1: BOP; HOBt
3.2: trifluoroacetic acid / CH2Cl2 / 0.5 h
3.3: 35 percent / iPr2NEt; acetic acid / dioxane / 24 h / 25 °C
View Scheme
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Boc-Gly

Boc-Gly

Gramicidin S
113-73-5

Gramicidin S

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1.1: HOBt; EDCI / CH2Cl2 / 3 h / 0 - 20 °C
2.1: HCl / dioxane / 0.5 h / 20 °C
3.1: HOBt; EDCI / CH2Cl2 / 3 h / 0 - 20 °C
4.1: HCl / dioxane / 0.5 h / 20 °C
5.1: 3.21 g / HOBt; EDCI / CH2Cl2 / 3 h / 0 - 20 °C
6.1: hydrogen / Pd/C / methanol / 15 h
7.1: 1.90 g / NaOH / methanol; dioxane; H2O / 15 h / 20 °C
8.1: BOP; HOBt
8.2: trifluoroacetic acid / CH2Cl2 / 0.5 h
8.3: 35 percent / iPr2NEt; acetic acid / dioxane / 24 h / 25 °C
View Scheme
H-Orn(Z)-OBzl
73995-50-3

H-Orn(Z)-OBzl

Gramicidin S
113-73-5

Gramicidin S

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1.1: HOBt; EDCI / CH2Cl2 / 3 h / 0 - 20 °C
2.1: HCl / dioxane / 0.5 h / 20 °C
3.1: HOBt; EDCI / CH2Cl2 / 3 h / 0 - 20 °C
4.1: HCl / dioxane / 0.5 h / 20 °C
5.1: 3.21 g / HOBt; EDCI / CH2Cl2 / 3 h / 0 - 20 °C
6.1: hydrogen / Pd/C / methanol / 15 h
7.1: 1.90 g / NaOH / methanol; dioxane; H2O / 15 h / 20 °C
8.1: BOP; HOBt
8.2: trifluoroacetic acid / CH2Cl2 / 0.5 h
8.3: 35 percent / iPr2NEt; acetic acid / dioxane / 24 h / 25 °C
View Scheme
C70H110N12O15
1054661-52-7

C70H110N12O15

Gramicidin S
113-73-5

Gramicidin S

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 1.19 g / N-hydroxybenzotriazole hydrate; diisopropylethylamine; PyBOP / dimethylformamide / 16 h
2: 78 percent / CF3CO2H / CH2Cl2 / 0.5 h
View Scheme
cyclo(Val-Orn(For)-Leu-D-Phe-Pro)2

cyclo(Val-Orn(For)-Leu-D-Phe-Pro)2

Gramicidin S
113-73-5

Gramicidin S

Conditions
ConditionsYield
With hydrogenchloride In methanol at 37℃; for 21h;
C45H61N7O8S

C45H61N7O8S

A

Gramicidin S
113-73-5

Gramicidin S

B

cyclo(D-Phe-Pro-Val-Orn-Leu)

cyclo(D-Phe-Pro-Val-Orn-Leu)

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: water; 3,3-dimethyldioxirane / acetone / 0.17 h / 23 °C
2: water; oxalic acid / N,N-dimethyl-formamide / 48 h / 40 °C
View Scheme
C36H47N5O8

C36H47N5O8

A

Gramicidin S
113-73-5

Gramicidin S

B

cyclo(D-Phe-Pro-Val-Orn-Leu)

cyclo(D-Phe-Pro-Val-Orn-Leu)

Conditions
ConditionsYield
With water; oxalic acid In N,N-dimethyl-formamide at 40℃; for 48h;
C68H98N12O13
1387574-96-0

C68H98N12O13

Gramicidin S
113-73-5

Gramicidin S

Conditions
ConditionsYield
With water; oxalic acid In N,N-dimethyl-formamide at 40℃; for 48h;3.6 mg
1-(tert-butoxycarbonyl)-L-proline
15761-39-4

1-(tert-butoxycarbonyl)-L-proline

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

N-tert-butoxycarbonyl-L-leucine
13139-15-6

N-tert-butoxycarbonyl-L-leucine

(R)-5-(benzyloxycarbonylamino)-2-(tert-butoxycarbonylamino)pentanoic acid
2480-93-5, 16937-92-1

(R)-5-(benzyloxycarbonylamino)-2-(tert-butoxycarbonylamino)pentanoic acid

Boc-D-Phe-OH
18942-49-9

Boc-D-Phe-OH

Gramicidin S
113-73-5

Gramicidin S

Conditions
ConditionsYield
Stage #1: N-tert-butoxycarbonyl-L-leucine With benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide
Stage #2: With trifluoroacetic acid In dichloromethane
Stage #3: 1-(tert-butoxycarbonyl)-L-proline; t-Boc-L-valine; (R)-Nδ-benzyloxycarbonyl-Nα-(tert-butoxycarbonyl)-ornithine; Boc-D-Phe-OH Further stages;
C75H114N15O12PolS

C75H114N15O12PolS

Gramicidin S
113-73-5

Gramicidin S

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In tetrahydrofuran at 20℃; for 6h; aminomethyl resin;55 mg
Fmoc-Val-OH
68858-20-8

Fmoc-Val-OH

Fmoc-Leu-OH
35661-60-0

Fmoc-Leu-OH

Fmoc-D-Phe-OH
86123-10-6

Fmoc-D-Phe-OH

(R)-Pyrrolidine-1,2-dicarboxylic acid 1-(9H-fluoren-9-ylmethyl) ester
71989-31-6, 109425-54-9, 144829-96-9, 101555-62-8

(R)-Pyrrolidine-1,2-dicarboxylic acid 1-(9H-fluoren-9-ylmethyl) ester

Fmoc-Lys(pg)-OH

Fmoc-Lys(pg)-OH

Gramicidin S
113-73-5

Gramicidin S

Conditions
ConditionsYield
Stage #1: Fmoc-D-Phe-OH With benzotriazol-1-ol; N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In dichloromethane; N,N-dimethyl-formamide for 1.5h;
Stage #2: With piperidine In N,N-dimethyl-formamide for 0.166667h;
Stage #3: Fmoc-Val-OH; Fmoc-Leu-OH; (R)-Pyrrolidine-1,2-dicarboxylic acid 1-(9H-fluoren-9-ylmethyl) ester; Fmoc-Lys(pg)-OH Further stages;
ethyl trifluoroacetate,
383-63-1

ethyl trifluoroacetate,

Gramicidin S
113-73-5

Gramicidin S

C64H90F6N12O12
86194-28-7

C64H90F6N12O12

Conditions
ConditionsYield
With triethylamine In methanol Ambient temperature;83%
Gramicidin S
113-73-5

Gramicidin S

methyl iodide
74-88-4

methyl iodide

C66H106N12O10(2+)*2I(1-)
99437-06-6

C66H106N12O10(2+)*2I(1-)

Conditions
ConditionsYield
With potassium hydrogencarbonate In methanol for 45h; Ambient temperature;75%
With potassium hydrogencarbonate In methanol Ambient temperature;75%
2,5-dioxopyrrolidin-(meta-diphenylphosphino)benzoate
1422391-48-7

2,5-dioxopyrrolidin-(meta-diphenylphosphino)benzoate

Gramicidin S
113-73-5

Gramicidin S

N,N'-(3,3'-((6R,9S,12S,15S,17aS,23R,26S,29S,32S,34aS)-6,23-dibenzyl-9,26-diisobutyl-15,32-diisopropyl-5,8,11,14,17,22,25,28,31,34-decaoxotetratriacontahydrodipyrrolo[1,2-a:1',2'-p] [1,4,7,10,13,16,19,22,25,28]decaazacyclotriacontine-12,29-diyl)bis(propane-3,1-diyl))bis(3-(diphenylphosphino)benzamide)
1422391-49-8

N,N'-(3,3'-((6R,9S,12S,15S,17aS,23R,26S,29S,32S,34aS)-6,23-dibenzyl-9,26-diisobutyl-15,32-diisopropyl-5,8,11,14,17,22,25,28,31,34-decaoxotetratriacontahydrodipyrrolo[1,2-a:1',2'-p] [1,4,7,10,13,16,19,22,25,28]decaazacyclotriacontine-12,29-diyl)bis(propane-3,1-diyl))bis(3-(diphenylphosphino)benzamide)

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 16h; Inert atmosphere;48%
2,5-dioxopyrrolidin-(para-diphenylphosphino)benzoate

2,5-dioxopyrrolidin-(para-diphenylphosphino)benzoate

Gramicidin S
113-73-5

Gramicidin S

N,N'-(3,3'-((6R,9S,12S,15S,17aS,23R,26S,29S,32S,34aS)-6,23-dibenzyl-9,26-diisobutyl-15,32-diisopropyl-5,8,11,14,17,22,25,28,31,34 decaoxotetratriacontahydro dipyrrolo[1,2-a:1',2'-p] [1,4,7,10,13,16,19,22,25,28] decaazacyclotriacontine-12,29-diyl)bis(propane-3,1-diyl))bis(4-(diphenylphosphino)benzamide)
1422391-50-1

N,N'-(3,3'-((6R,9S,12S,15S,17aS,23R,26S,29S,32S,34aS)-6,23-dibenzyl-9,26-diisobutyl-15,32-diisopropyl-5,8,11,14,17,22,25,28,31,34 decaoxotetratriacontahydro dipyrrolo[1,2-a:1',2'-p] [1,4,7,10,13,16,19,22,25,28] decaazacyclotriacontine-12,29-diyl)bis(propane-3,1-diyl))bis(4-(diphenylphosphino)benzamide)

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 16h; Inert atmosphere;48%
Gramicidin S
113-73-5

Gramicidin S

2,5-dioxopyrrolidin-1-yl 2-(diphenylphosphanyl)benzoate
291286-47-0

2,5-dioxopyrrolidin-1-yl 2-(diphenylphosphanyl)benzoate

N,N'-(3,3'-((6R,9S,12S,15S,17aS,23R,26S,29S,32S,34aS)-6,23-dibenzyl-9,26-diisobutyl-15,32-diisopropyl-5,8,11,14,17,22,25,28,31,34-decaoxotetratriacontahydrodipyrrolo[1,2-a:1',2'-p][1,4,7,10,13,16,19,22,25,28]decaazacyclotriacontine-12,29-diyl)bis(propane-3,1-diyl))bis(2-(diphenylphosphino)benzamide)
1422391-47-6

N,N'-(3,3'-((6R,9S,12S,15S,17aS,23R,26S,29S,32S,34aS)-6,23-dibenzyl-9,26-diisobutyl-15,32-diisopropyl-5,8,11,14,17,22,25,28,31,34-decaoxotetratriacontahydrodipyrrolo[1,2-a:1',2'-p][1,4,7,10,13,16,19,22,25,28]decaazacyclotriacontine-12,29-diyl)bis(propane-3,1-diyl))bis(2-(diphenylphosphino)benzamide)

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 16h;39%
Gramicidin S
113-73-5

Gramicidin S

3-(diphenylphosphaneyl)propanoic acid N-hydroxysuccinimide ether

3-(diphenylphosphaneyl)propanoic acid N-hydroxysuccinimide ether

(6R,9S,12S,15S,17aS,23R,26S,29S,32S,34aS)-6,23-dibenzyl-12,29-bis(3-(3-(diphenylphosphino)propanoyloxyamino)propyl)-9,26-diisobutyl-15,32-diisopropyltetracosahydrodipyrrolo [1,2-a:1',2'-p] [1,4,7,10,13,16,19,22,25,28] decaaza cyclotriacontine-5,8,11,14,17,22,25,28,31,34-decaone

(6R,9S,12S,15S,17aS,23R,26S,29S,32S,34aS)-6,23-dibenzyl-12,29-bis(3-(3-(diphenylphosphino)propanoyloxyamino)propyl)-9,26-diisobutyl-15,32-diisopropyltetracosahydrodipyrrolo [1,2-a:1',2'-p] [1,4,7,10,13,16,19,22,25,28] decaaza cyclotriacontine-5,8,11,14,17,22,25,28,31,34-decaone

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 16h; Inert atmosphere;16.8%
5-(4-carboxyphenyl)-10,15,20-tris(4-methylphenyl) porphyrin
61449-63-6

5-(4-carboxyphenyl)-10,15,20-tris(4-methylphenyl) porphyrin

Gramicidin S
113-73-5

Gramicidin S

C156H160N20O12

C156H160N20O12

Conditions
ConditionsYield
With benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate; benzotriazol-1-ol Acylation;

113-73-5Relevant academic research and scientific papers

Rapid, Traceless, AgI-Promoted Macrocyclization of Peptides Possessing an N-Terminal Thioamide

Thombare, Varsha J.,Hutton, Craig A.

, p. 4998 - 5002 (2019)

Peptide macrocyclization is often a slow process, plagued by epimerization and cyclodimerization. Herein, we describe a new method for peptide macrocyclization employing the AgI-promoted transformation of peptide thioamides. The AgI has a dual function: chemoselectively activating the thioamide and tethering the N-terminal thioamide to the C-terminal carboxylate. Extrusion of Ag2S generates an isoimide intermediate, which undergoes acyl transfer to generate the native cyclic peptide, resulting in a rapid, traceless macrocylization process. Cyclic peptides are furnished in high yields within 1 hour, free of epimerization and cyclodimerization.

Design and Discovery of Natural Cyclopeptide Skeleton Based Programmed Death Ligand 1 Inhibitor as Immune Modulator for Cancer Therapy

Sun, Haixia,Chen, Daoyuan,Zhan, Siyue,Wu, Weijian,Xu, Huiying,Luo, Chunxiang,Su, Hui,Feng, Yanqiao,Shao, Weiyan,Wan, Arabella,Zhou, Binhua,Wan, Guohui,Bu, Xianzhang

, p. 11286 - 11301 (2020)

Blockade of immune checkpoint PD-1/PD-L1 facilitates the rescue of immune escapes of tumor cells. Though various monoclonal antibodies have been approved for clinical therapy, the development of small molecular inhibitors lags behind antibodies partially owing to the challenges of protein-protein interaction (PPI) blocker design. In this work, we adopted the skeleton of natural cyclopeptidic antibiotics gramicidin S as the start point for PD-1/PD-L1 inhibitor exploring and discovered a series of novel cyclopeptides that could interfere with the PPI of PD-1/PD-L1 based on several rounds of structural design and optimization. The representative active cyclopeptide 66 can bind two PD-L1 and efficiently block the PD-1/PD-L1 interaction, recruit the immune cells to the tumor cells, enhance their killing against tumor cells by promoting the release of granzyme B and perforin, and display significant CD8+ T cell-dependent tumor suppression activity in vivo.

Development of Therapeutic Gramicidin S Analogues Bearing Plastic β,γ-Diamino Acids

Alezra, Valérie,Chen, Kaisen,Chen, Qiang,Cheng, Keguang,Guan, Qinkun,Hu, Chengfei,Hu, Jianguo,Jin, Yi,Miclet, Emeric,Wan, Yang,Zhu, Jibao

, (2020)

Gramicidin S (GS), one of the most widely investigated antimicrobial peptides (AMPs), is known for its robust antimicrobial activity. However, it is restricted to topical application due to undesired hemolytic activity. With the aim of obtaining nontoxic GS analogues, we describe herein a molecular approach in which the native GS β-turn region is replaced by synthetic β,γ-diamino acids (β,γ-DiAAs). Four β,γ-DiAA diastereomers were employed to mimic the β-turn structure to afford GS analogues GS3–6, which exhibit diminished hemolytic activity. A comparative structural study demonstrates that the (βR,γS)-DiAA is the most-stable β-turn mimic. To further improve the therapeutic index (e. g., high antibacterial activity and low hemolytic activity) and to extend the molecular diversity, GS5 and GS6 were used as structural scaffolds to introduce additional hydrophobic or hydrophilic groups. We show that GS6K, GS6F and GS display comparable antibacterial activity, and GS6K and GS6F have significantly decreased toxicity. Moreover, antibacterial mechanism studies suggest that GS6K kills bacteria mainly through the disruption of the membrane.

Synthesis of Gramicidin S and Its Analogues via an On-Resin Macrolactamization Assisted by a Predisposed Conformation of the Linear Precursors

Bu, Xianzhang,Wu, Xiaoming,Ng, Na Lee Joyce,Mak, Chun Kit,Qin, Chuanguang,Guo, Zhihong

, p. 2681 - 2685 (2004)

A simple and efficient preparation of gramicidin S and its analogues is described. It involves solid-phase peptide synthesis and on-resin macrolactamization without side chain protection, affording cyclic products in high yield and high purity. The high specificity of the cyclization reaction was shown to originate in the formation of a pre-organized conformation of the linear biosynthetic precursor of gramicidin S. This facile method will provide convenient access to the analogues of the natural product for functional optimization to counter microbial resistance.

Spatially close porphyrin pair linked by the cyclic peptide Gramicidin S

Arai, Toru,Maruo, Naoki,Sumida, Yuko,Korosue, Chie,Nishino, Norikazu

, p. 1503 - 1504 (1999)

Two porphyrins were attached to the cyclic decapeptide Gramicidin S and its analogs via the side chain amide bonds and the solvent-dependent molecular structure was characterized by various spectroscopic methods.

Relationship between the cyclization and conformation of pentapeptide active esters related to gramicidin S having no protecting group on the side chain of the ornithine residue

Tamaki, Makoto,Komiya, Seiji,Akabori, Sadatoshi,Muramatsu, Ichiro

, p. 899 - 904 (1997)

To investigate the contribution of the D-phe-Pro-Val sequence in the direct formation of gramicidin S (GS) by the dimerization-cyclization of pentapeptide-active esters having no protecting group on the side chain of the Orn residue, the cyclization of four H-X-Pro-Y-Orn-Leu-ONSu's (X = L- or D-Phe, Y = L- or D-Val, -ONSu = succinimide ester) was examined. Only H-D-Phe-Pro-Val-Orn-Leu-ONSu gave semi-GS (cyclic monomer) and GS (cyclic dimer) in yields of 15 and 38%, respectively. The active ester with a D-Phe-Pro-D-Val sequence produced exclusively [D-Val]-semi-GS in 58% yield. On the other hand, the active esters having Phe-Pro-Val and Phe-Pro-D-Val sequences did not yield any amount of cyclic monomer and cyclic dimer. The change in the configurations of the Phe and Val residues around the Pro residue greatly affected the CD spectra in ethanol and the 1H NMR spectra in DMSO-d6 of the pentapeptide ethyl esters corresponding to four H-X-Pro-Y-Orn-Leu-ONSu's. A good correlation among the CD spectra, NMR spectra of the pentapeptide ethyl esters, and the main products in the cyclization of the active esters was found.

Synthetic Lugdunin Analogues Reveal Essential Structural Motifs for Antimicrobial Action and Proton Translocation Capability

Schilling, Nadine A.,Berscheid, Anne,Schumacher, Johannes,Saur, Julian S.,Konnerth, Martin C.,Wirtz, Sebastian N.,Beltrán-Bele?a, José M.,Zipperer, Alexander,Krismer, Bernhard,Peschel, Andreas,Kalbacher, Hubert,Br?tz-Oesterhelt, Heike,Steinem, Claudia,Grond, Stephanie

, p. 9234 - 9238 (2019)

Lugdunin, a novel thiazolidine cyclopeptide, exhibits micromolar activity against methicillin-resistant Staphylococcus aureus (MRSA). For structure–activity relationship (SAR) studies, synthetic analogues obtained from alanine and stereo scanning as well as peptides with modified thiazolidine rings were tested for antimicrobial activity. The thiazolidine ring and the alternating d- and l-amino acid backbone are essential. Notably, the non-natural enantiomer displays equal activity, thus indicating the absence of a chiral target. The antibacterial activity strongly correlates with dissipation of the membrane potential in S. aureus. Lugdunin equalizes pH gradients in artificial membrane vesicles, thereby maintaining membrane integrity, which demonstrates that proton translocation is the mode of action (MoA). The incorporation of extra tryptophan or propargyl moieties further expands the diversity of this class of thiazolidine cyclopeptides.

Biomimetic synthesis of gramicidin s and analogues by enzymatic cyclization of linear precursors on solid support.

Wu, Xiaoming,Bu, Xianzhang,Wong, Ka Man,Yan, Weili,Guo, Zhihong

, p. 1749 - 1752 (2003)

[reaction: see text] Gramicidin S is a potent decapeptide antibiotic with high hemolytic activity but is unlikely to provoke microbial resistance. Here we demonstrate that gramicidin thioesterase (GrsB TE) correctly cyclizes immobilized linear decapeptide precursors into head-to-tail products, indicating its suitability for parallel solid-phase synthesis of gramicidin analogues from linear precursors on solid support. This chemoenzymatic method will enable the optimization of the therapeutic index of the natural product to fight microbial resistance.

IBTM-containing gramicidin S analogues: Evidence for IBTM as a suitable type II' β-turn mimetic

Andreu, David,Ruiz, Sergi,Carre?o, Cristina,Alsina, Jordi,Albericio, Fernando,Jiménez, María Angeles,De La Figuera, Natalia,Herranz, Rosario,García-López, María Teresa,González-Mu?iz, Rosario

, p. 10579 - 10586 (1997)

The 2-amino-3-oxohexahydroindolizino[8,7-b]indole-5-carboxylate system (IBTM) has been proposed as a dipeptide surrogate of type II' β-turns. To evaluate which of the 11bR and 11bS diastereomers of IBTM best reproduces the conformational properties of type II' β-turns, gramicidin S (GS), a cyclic antibiotic peptide that contains two such units, has been chosen as a test compound and the effect of either diastereomer on both conformation and activity of the resulting peptide analogues has been determined. A conventional approach to the cyclic peptide structure based on solution cyclization of a partially protected precursor was only practicable for the (S)IBTM diastereomer. As an alternative, a solid phase mediated cyclization approach has been devised and applied successfully to both gramicidin S and its Lys2,2' analogue, then extended to the (R)-IBTM-containing analogues. NMR conformational analysis has clearly shown that only the (R) diastereomer of IBTM is a suitable mimic of the type II' β-turn conformation typical of GS. Differences in antibacterial activity between the (S)- and (R)-IBTM-containing GS analogues confirm the conformational results.

Stabilization of Cyclic β-Hairpins by Ugi-Reaction-Derived N-Alkylated Peptides: The Quest for Functionalized β-Turns

Ricardo, Manuel G.,Vasco, Aldrin V.,Rivera, Daniel G.,Wessjohann, Ludger A.

supporting information, p. 7307 - 7310 (2019/10/02)

A solid-phase approach including on-resin Ugi reactions was developed for the construction of β-hairpins. Various N-alkylated dipeptide fragments proved capable of aligning antiparallel β-sheets in a macrocyclic scaffold, thus serving as β-hairpin templates. Gramicidin S was used as the model β-hairpin to compare the Ugi-derived β-turns with the type-II′ β-turn. The results show that the multicomponent incorporation of such N-alkylated residues allows for the simultaneous stabilization and exo-cyclic functionalization of cyclic β-hairpins.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 113-73-5